144 related articles for article (PubMed ID: 28457729)
1. Genetic profile of ductal adenocarcinoma of the prostate.
Seipel AH; Whitington T; Delahunt B; Samaratunga H; Mayrhofer M; Wiklund P; Grönberg H; Lindberg J; Egevad L
Hum Pathol; 2017 Nov; 69():1-7. PubMed ID: 28457729
[TBL] [Abstract][Full Text] [Related]
2. Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar adenocarcinoma.
Amin A; Epstein JI
Am J Surg Pathol; 2011 Apr; 35(4):615-9. PubMed ID: 21383610
[TBL] [Abstract][Full Text] [Related]
3. Ductal adenocarcinoma of the prostate: Clinical and biological profiles.
Vinceneux A; Bruyère F; Haillot O; Charles T; de la Taille A; Salomon L; Allory Y; Ouzaid I; Choudat L; Rouprêt M; Comperat E; Houede N; Beauval JB; Vourc'h P; Fromont G
Prostate; 2017 Sep; 77(12):1242-1250. PubMed ID: 28699202
[TBL] [Abstract][Full Text] [Related]
4. Multiple Origin and Tumor Heterogeneity of Prostatic Ductal Adenocarcinoma in the Han Chinese Population.
Zhang W; Su F; Wang M; Hou H; Liu M; Liu D; Liu H
Genet Test Mol Biomarkers; 2021 Nov; 25(11):727-732. PubMed ID: 34788144
[No Abstract] [Full Text] [Related]
5. Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study.
Seipel AH; Samaratunga H; Delahunt B; Wiklund P; Clements M; Egevad L
APMIS; 2016 Apr; 124(4):263-70. PubMed ID: 26778368
[TBL] [Abstract][Full Text] [Related]
6. Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations.
Khani F; Wobker SE; Hicks JL; Robinson BD; Barbieri CE; De Marzo AM; Epstein JI; Pritchard CC; Lotan TL
J Pathol; 2019 Sep; 249(1):79-89. PubMed ID: 30993692
[TBL] [Abstract][Full Text] [Related]
7. PIN-like (Ductal) Adenocarcinoma of the Prostate.
Paulk A; Giannico G; Epstein JI
Am J Surg Pathol; 2018 Dec; 42(12):1693-1700. PubMed ID: 30138215
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate.
Sanati S; Watson MA; Salavaggione AL; Humphrey PA
Mod Pathol; 2009 Oct; 22(10):1273-9. PubMed ID: 19633648
[TBL] [Abstract][Full Text] [Related]
9. Integrative Genomic Analysis of Coincident Cancer Foci Implicates CTNNB1 and PTEN Alterations in Ductal Prostate Cancer.
Gillard M; Lack J; Pontier A; Gandla D; Hatcher D; Sowalsky AG; Rodriguez-Nieves J; Vander Griend D; Paner G; VanderWeele D
Eur Urol Focus; 2019 May; 5(3):433-442. PubMed ID: 29229583
[TBL] [Abstract][Full Text] [Related]
10. Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension.
Samaratunga H; Duffy D; Yaxley J; Delahunt B
Hum Pathol; 2010 Feb; 41(2):281-5. PubMed ID: 20004936
[TBL] [Abstract][Full Text] [Related]
11. Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens.
Seipel AH; Wiklund F; Wiklund NP; Egevad L
Virchows Arch; 2013 Apr; 462(4):429-36. PubMed ID: 23443941
[TBL] [Abstract][Full Text] [Related]
12. Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features.
Seipel AH; Delahunt B; Samaratunga H; Egevad L
Pathology; 2016 Aug; 48(5):398-405. PubMed ID: 27321992
[TBL] [Abstract][Full Text] [Related]
13. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
14. PIN-like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations.
Kaur HB; Salles DC; Paulk A; Epstein JI; Eshleman JR; Lotan TL
Histopathology; 2021 Jan; 78(2):327-333. PubMed ID: 32740981
[TBL] [Abstract][Full Text] [Related]
15. PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.
Morais CL; Herawi M; Toubaji A; Albadine R; Hicks J; Netto GJ; De Marzo AM; Epstein JI; Lotan TL
Prostate; 2015 Oct; 75(14):1610-9. PubMed ID: 26178158
[TBL] [Abstract][Full Text] [Related]
16. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
17. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
[TBL] [Abstract][Full Text] [Related]
18. Correlation between cribriform/intraductal prostatic adenocarcinoma and percent Gleason pattern 4 to a 22-gene genomic classifier.
Taylor AS; Morgan TM; Wallington DG; Chinnaiyan AM; Spratt DE; Mehra R
Prostate; 2020 Feb; 80(2):146-152. PubMed ID: 31737920
[TBL] [Abstract][Full Text] [Related]
19. A novel non-canonical Wnt signature for prostate cancer aggressiveness.
Sandsmark E; Hansen AF; Selnæs KM; Bertilsson H; Bofin AM; Wright AJ; Viset T; Richardsen E; Drabløs F; Bathen TF; Tessem MB; Rye MB
Oncotarget; 2017 Feb; 8(6):9572-9586. PubMed ID: 28030815
[TBL] [Abstract][Full Text] [Related]
20. Improved differentiation between ductal and acinar prostate cancer using three-dimensional histology and biomarkers.
Tarján M; Chen HH; Tot T; Wu W; Lenngren A; Dean PB; Tabár L
Scand J Urol Nephrol; 2012 Aug; 46(4):258-66. PubMed ID: 22519924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
